Piper Jaffray Has Positive Outlook On St. Jude Medical Ahead Of 3Q14 Earnings

By: via Benzinga
In a report published Monday, Piper Jaffray analyst Brooks E. West reiterated an Overweight rating and $79.00 price target on St. Jude ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.